GlassScriptPhysician profile
Cheryl M Cohler
NPI 1962454041
$6,342.79
in general payments reported to CMS, 2019-2025
54 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $679 · 2021: $789 · 2022: $635 · 2023: $891 · 2024: $1,116 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,987 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,987.07 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,713.26 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $1,004.04 | 2019-2025 | Evenity, Prolia, Repatha |
| Astellas Pharma US INC | $440.71 | 2019-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $331.80 | 2019-2025 | |
| Pfizer INC. | $299.58 | 2021-2025 | |
| Abbott Laboratories | $225.78 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Allergan, INC. | $225.21 | 2020 | |
| Merck Sharp & Dohme LLC | $201.23 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Glaxosmithkline, LLC. | $190.67 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $97.93 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $93.04 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.20 | 2019-2024 | Xifaxan |
| Lilly USA, LLC | $72.75 | 2019-2024 | Zepbound, Jardiance |
| Teva Pharmaceuticals USA, INC. | $70.60 | 2019-2025 | Austedo Xr |
| Genentech USA, INC. | $66.71 | 2019-2021 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $62.95 | 2021-2024 | Bd Affirm Vpiii Microbial Identification Test, Bd Max System, Bd Max Instrument |
| Otsuka America Pharmaceutical, INC. | $60.21 | 2023-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.13 | 2020-2025 | Jardiance |
| Grifols USA, LLC | $57.19 | 2024-2025 | Prolastin-C Liquid |
| Radius Health, INC. | $55.80 | 2020-2025 | Tymlos |
| Nevro Corp. | $55.58 | 2024 | Senza |
| Hologic Sales and Service, LLC | $54.67 | 2022-2024 | Thinprep 2000 Processor, Aptima |
| Depuy Synthes Sales INC. | $44.79 | 2019-2022 | |
| Novo Nordisk INC | $44.35 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $43.45 | 2020-2025 | Farxiga, Airsupra |
| Phadia US INC. | $42.42 | 2019-2021 | |
| Boston Scientific Corporation | $40.80 | 2024-2025 | Intracept |
| Amarin Pharma, INC. | $38.66 | 2020 | |
| Phathom Pharmaceuticals, INC. | $34.42 | 2024-2025 | Voquezna |
| Sanofi Pasteur INC. | $34.22 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.84 | 2023-2024 | |
| Lundbeck LLC | $30.70 | 2024 | Rexulti |
| Aimmune Therapeutics, INC. | $30.17 | 2025 | Vowst |
| Neos Therapeutics, LP | $30.01 | 2025 | Adzenys Xr-Odt |
| Eisai INC. | $29.83 | 2020-2025 | |
| Nestle Healthcare Nutrition INC. | $24.13 | 2021 | |
| Esperion Therapeutics, INC. | $23.64 | 2023 | Nexletol |
| Sk Life Science, INC. | $22.16 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $22.07 | 2023 | Dupixent |
| Shield Therapeutics INC | $22.04 | 2023 | Accrufer |
| Kowa Pharmaceuticals America, INC. | $21.88 | 2024 | Zoryve |
| Sumitomo Pharma America, INC. | $20.26 | 2025 | Gemtesa |
| Angiodynamics, INC. | $20.17 | 2022 | |
| Bausch Health US, LLC | $19.79 | 2020 | |
| Endogastric Solutions, INC | $18.77 | 2019-2023 | Esophyx |
| Acerus Pharmaceuticals Corporation | $17.20 | 2022 | |
| Medtronic, INC. | $16.56 | 2022 | |
| Corium, LLC | $16.44 | 2022 | |
| Exact Sciences Corporation | $15.24 | 2023 | Cologuard Collection Kit |
| Alnylam Pharmaceuticals INC. | $14.92 | 2023 | Onpattro |
| Therapeuticsmd, INC. | $14.66 | 2019 | |
| Advanced Respiratory, INC | $14.61 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.05 | 2020 | |
| Ibsa Pharma INC. | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Cohler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.